arrow_back Back to App

Securing Gene Synthesis: New Rules for Screening Synthetic Genetic Material.

This Act mandates new, strict security protocols for companies that produce synthetic genetic material (DNA/RNA). The goal is to prevent the misuse of these products, such as for bioterrorism. Federal-funded research institutions must purchase these materials only from verified providers who comply with the new screening requirements.
Key points
Requires mandatory screening protocols for companies manufacturing synthetic DNA and RNA to detect potential misuse of the products.
Federal agencies and entities receiving federal funds must only purchase gene synthesis products from verified, compliant providers.
Non-compliance with the new security rules can lead to the revocation or withholding of Federal research funding.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_2400
Sponsor: Sen. Markey, Edward J. [D-MA]
Process start date: 2023-07-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Securing Gene Synthesis Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_2400.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-07-19.

What are the main provisions?

Key points include:

  • Requires mandatory screening protocols for companies manufacturing synthetic DNA and RNA to detect potential misuse of the products.
  • Federal agencies and entities receiving federal funds must only purchase gene synthesis products from verified, compliant providers.
  • Non-compliance with the new security rules can lead to the revocation or withholding of Federal research funding.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Markey, Edward J. [D-MA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Security